ctDNA-guided adjuvant atezolizumab improves OS in MIBC

ctDNA-guided adjuvant chemo de-escalation reduces toxicity with comparable outcomes in stage III colon cancer

MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection

Circulating tumour DNA a useful marker in CRC treatment efficacy, but only alongside others

Improving efficacy and toxicity reporting - and treatment insights from an oncologist patient

Future of chemotherapy and targeted therapies

Latest advances in chronic lymphocytic leukaemia

Advancements in gastrointestinal cancer treatments at ASCO 2025

Updates on gastrointestinal cancer treatments ASCO 2025

Memorial Cancer Institute's Best of ASCO® 2025

Florida Atlantic University and Memorial Cancer Institute collaboration

ASCO 2025: Developments in the treatment of soft tissue sarcoma